144 ·Filed Jul 27, 2026

MEDP

Medpace Holdings, Inc.
BEARISH
Impact 5/10
Horizondays Processed2mo ago SEC0001969223-26-000803
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

Monitor for actual execution of the 144 notice in subsequent Form 4 filings. A completed sale of this magnitude by the chairman could signal reduced insider conviction and may pressure the stock near-term. Watch for any concurrent open-market purchases by other insiders or the company's buyback activity as a counter-signal.

DirectionBearish
Confidencemedium
Horizondays
Latest settled — T+20d
MEDP ▲ +7.55% at T+20d
SHORT call ✗ call lost -7.55% · α vs SPY -4.17% · entry $570.97 → $614.06
Next anchor: T+60d in 18d
Latest observation: T+47 +21.38% FF3 residual α
Entry anchored
Jul 27, 03:59 PM ET
via exchange tick
T+1d
+2.44%
call -2.44% · α -3.98%
$584.93
settled 2mo ago
T+5d
+0.41%
call -0.41% · α +1.86%
$573.29
settled 2mo ago
T+20d
+7.55%
call -7.55% · α -4.17%
$614.06
settled 6w ago
T+60d
—
call — · α —
—
in 18d

Price Chart

Loading chart...

Executive Summary

Chairman August J. Troendle filed a Form 144 notice of intent to sell 307,959 shares of Medpace common stock, valued at approximately $184.8 million based on the filing date. This represents a substantial proposed sale by the company's founder and chairman, signaling potential insider distribution at a $17.2B market cap company. The filing is an advance notice of intent, not a completed sale, but the magnitude relative to market cap (~1.1%) and the insider's role make it a notable event for traders to monitor for execution.

Key Facts

  • Chairman August J. Troendle filed Form 144 to sell 307,959 shares
  • Estimated value of proposed sale: ~$184.8 million
  • Shares acquired via NQ stock options exercised on 03/07/2025
  • Sale is to be executed through UBS Financial Services Inc
  • Troendle is also trustee of The August J. Troendle Revocable Trust

Financial Impact

Proposed sale of 307,959 shares valued at ~$184.8 million, representing ~1.1% of Medpace's $17.2B market cap

insider ownershipfloat

Risk Factors

  • Form 144 is an intent to sell — the sale may not be executed or may be modified
  • Large insider sale could be for personal diversification or tax planning, not a negative signal about company fundamentals
  • CRO sector fundamentals remain strong; this is an insider-specific event

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
45% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-000803
Document: 0001969223-26-000803-index.html0001969223-26-000803
Document: 0001969223-26-000803.txt0001969223-26-000803
15 reports for MEDP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MEDP — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$593.99 $622.11▲ +4.73%▲ +4.92%$606.24 (+2.06%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$600.65 $615.94▲ +2.55%▲ +2.29%$606.24 (+0.93%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$611.57 $620.59▲ +1.47%▲ +1.98%$606.24 (−0.87%)
Aug 25, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$614.06 $617.15▼ −0.50%▲ +0.47%$606.24 (+1.27%)
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$620.03 $630.19▲ +1.64%▲ +0.32%$606.24 (−2.22%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$620.75 $624.20▲ +0.56%▲ +1.08%$606.24 (−2.34%)
Aug 19, 2026
6w ago
144
NEUTRAL ★ 3/10
$608.27 $615.18▲ +1.14%▲ +3.09%$606.24 (−0.33%)
Aug 14, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$578.50 $595.41▲ +2.92%▲ +4.91%$606.24 (+4.80%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$581.95 $587.52▲ +0.96%▲ +2.70%$606.24 (+4.17%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$596.98 $583.16▼ −2.31%▼ −0.42%$606.24 (+1.55%)
Showing 10 of 15

US Market Status

Market Open — Closes in 3h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access